Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Endoscopy. 2023 Dec;55(12):1061-1069. doi: 10.1055/a-2136-6564. Epub 2023 Oct 4.
BACKGROUND: In the Dutch colorectal (CRC) screening program, fecal immunochemical test (FIT)-positive individuals are referred for colonoscopy. If no relevant findings are detected at colonoscopy, individuals are reinvited for FIT screening after 10 years. We aimed to assess CRC risk after a negative colonoscopy in FIT-positive individuals. METHODS: In this cross-sectional cohort study, data were extracted from the Dutch national screening information system. Participants with a positive FIT followed by a negative colonoscopy between 2014 and 2018 were included. A negative colonoscopy was defined as a colonoscopy during which no more than one nonvillous, nonproximal adenoma < 10 mm or serrated polyp < 10 mm was found. The main outcome was interval post-colonoscopy CRC (iPCCRC) risk. iPCCRC risk was reviewed against the risk of interval CRC after a negative FIT (FIT IC) with a 2-year screening interval. RESULTS: 35 052 FIT-positive participants had a negative colonoscopy and 24 iPCCRCs were diagnosed, resulting in an iPCCRC risk of 6.85 (95 %CI 4.60-10.19) per 10 000 individuals after a median follow-up of 1.4 years. After 2.5 years of follow-up, age-adjusted iPCCRC risk was approximately equal to FIT IC risk at 2 years. CONCLUSION: Risk of iPCCRC within a FIT-based CRC screening program was low during the first years after colonos-copy but, after 2.5 years, was the same as the risk in FIT-negative individuals at 2 years, when they are reinvited for screening. Colonoscopy quality may therefore require further improvement and FIT screening interval may need to be reduced after negative colonoscopy.
背景:在荷兰结直肠癌(CRC)筛查计划中,粪便免疫化学测试(FIT)阳性者将被转介进行结肠镜检查。如果结肠镜检查未发现相关发现,将在 10 年后再次邀请这些人进行 FIT 筛查。我们旨在评估 FIT 阳性者结肠镜检查阴性后的 CRC 风险。
方法:在这项横断面队列研究中,数据从荷兰国家筛查信息系统中提取。纳入 2014 年至 2018 年间进行阳性 FIT 检查后阴性结肠镜检查的参与者。阴性结肠镜检查定义为结肠镜检查期间仅发现不超过一个非绒毛、非近端腺瘤<10mm 或锯齿状息肉<10mm。主要结局是结肠镜检查后间隔期 CRC(iPCCRC)风险。使用 2 年筛查间隔的阴性 FIT(FIT IC)后的间隔 CRC 风险来审查 iPCCRC 风险。
结果:35052 名 FIT 阳性者进行了阴性结肠镜检查,诊断出 24 例 iPCCRC,在中位随访 1.4 年后,每 10000 人中发生 iPCCRC 的风险为 6.85(95%CI 4.60-10.19)。随访 2.5 年后,年龄调整后的 iPCCRC 风险与 2 年时的 FIT IC 风险大致相同。
结论:在基于 FIT 的 CRC 筛查计划中,结肠镜检查后最初几年内 iPCCRC 的风险较低,但 2.5 年后,与 2 年时再次邀请进行筛查的 FIT 阴性者的风险相同。因此,结肠镜检查质量可能需要进一步提高,并且在阴性结肠镜检查后 FIT 筛查间隔可能需要缩短。
Clin Gastroenterol Hepatol. 2023-8
Lancet Gastroenterol Hepatol. 2022-8
Cancers (Basel). 2021-10-12
Ann Intern Med. 2020-5-26
Clin Chem. 2019-1-16
JAMA Intern Med. 2019-2-1